Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

ROTABLATOR VS. ANGIOPLASTY: REINTERVENTION RATE 11% HIGHER

This article was originally published in The Gray Sheet

Executive Summary

ROTABLATOR VS. ANGIOPLASTY: REINTERVENTION RATE 11% HIGHER for rotational atherectomy with the Rotablator than for percutaneous transluminal coronary angioplasty when performed on complex lesions, Michel Vandormael, Heart Center & Red Cross Hospital, Frankfurt, Germany, et al., reported Nov. 15 at the American Heart Association's Scientific Sessions in Dallas. The researchers' conclusion was based on nine-month follow-up of a 620-patient, single-center randomized trial investigating procedural and angiographic results in patients treated with rotational atherectomy, excimer laser angioplasty, and PTCA.
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT003112

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel